Agilux Laboratories Appoints Head of GLP Bioanalysis
News Apr 09, 2014
Rich joined Agilux in early 2012 as Senior Director, Bioanalytical Operations and has also served as a member of its senior management team since that time. In his new role, Rich will be directly responsible for driving the scientific, regulatory and operational processes and improvements within its GLP bioanalytical labs.
For nearly two decades, Rich’s focus has been in regulated bioanalysis, where he has held positions of increasing operational responsibility at notable contract research organizations. Rich is an active member of the Global Bioanalytical Consortium harmonization team for small molecule bioanalysis and is a noted speaker and instructor on bioanalytical mass spectrometry throughout North America, Europe, Japan, and China. He also continues to serve as the founder and co-instructor for the High Resolution Mass Spectrometry short course at the American Society for Mass Spectrometry annual meeting.
“Rich has brought vast knowledge and GLP bioanalytical expertise to our team here at Agilux and has been instrumental in driving our scientific, regulatory and operational process improvements to enable first-class bioanalytical services,” said Jim Jersey, President and CEO. “We look forward to his future contributions and regulatory insight in this new role, and fully expect his dynamic efforts to further advance our range of GLP services for our clients.
Steaming Fish Eliminates More Cyanotoxins Than BoilingNews
Utilizing UHPLC researchers have shown that steaming freshwater fish for more than two minutes reduces the presence of the cyanotoxin, cylindrospermopsin, by up to 26% compared to 18% for boiling.READ MORE
Tiny “Tornado” Boosts Performance of Electrospray Ionization Mass SpectrometryNews
Known as Dry Ion Localization and Locomotion (DRILL), the new device creates a swirling flow that can separate electrospray droplets depending on their size.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE